Jove
Visualize
Contact Us

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Generalization as the great leap in evolvability: insights from machine learning.

Evolution; international journal of organic evolution·2026
Same author

A control theoretical approach to gene regulation reveals quantitative constraints for dynamic homeostasis in stochastic gene expression.

Biochimica et biophysica acta. Molecular basis of disease·2026
Same author

The Price Equation Reveals a Universal Force-Metric-Bias Law of Algorithmic Learning and Natural Selection.

Entropy (Basel, Switzerland)·2025
Same author

Protein Kinase A Phosphorylates a Conformationally High-energy State of Raf Kinase Inhibitory Protein.

Journal of molecular biology·2025
Same author

Circuit Design in Biology and Machine Learning. II. Anomaly Detection.

Entropy (Basel, Switzerland)·2025
Same author

An enhanced transcription factor repressilator that buffers stochasticity and entrains to an erratic external circadian signal.

Frontiers in systems biology·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 23, 2026

Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

Nonheritable cellular variability accelerates the evolutionary processes of cancer.

Steven A Frank1, Marsha Rich Rosner

  • 1Department of Ecology and Evolutionary Biology, University of California, Irvine, California, United States of America. safrank@uci.edu

Plos Biology
|April 18, 2012
PubMed
Summary

Cancer evolution is driven by genetic changes and nonheritable cellular variability. Understanding nonheritable variability is crucial for developing new drug strategies to combat cancer drug resistance.

More Related Videos

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
10:24

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

Evaluating the Effect of SASP Factors on the Proliferation of Cancer Cells Using a Comparative Analysis of Three Distinct Methodologies
08:57

Evaluating the Effect of SASP Factors on the Proliferation of Cancer Cells Using a Comparative Analysis of Three Distinct Methodologies

Published on: September 19, 2025

Related Experiment Videos

Last Updated: May 23, 2026

Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
10:24

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

Evaluating the Effect of SASP Factors on the Proliferation of Cancer Cells Using a Comparative Analysis of Three Distinct Methodologies
08:57

Evaluating the Effect of SASP Factors on the Proliferation of Cancer Cells Using a Comparative Analysis of Three Distinct Methodologies

Published on: September 19, 2025

Area of Science:

  • Oncology
  • Evolutionary Biology
  • Genetics

Background:

  • Genetic and heritable epigenetic changes are known drivers of cancer progression and drug resistance.
  • The role of nonheritable cellular variability in cancer evolution is increasingly recognized.

Purpose of the Study:

  • To discuss how nonheritable aspects of cellular variability can accelerate cancer evolution.
  • To highlight the need for novel therapeutic strategies targeting nonheritable variability.

Main Methods:

  • Review of recent cancer studies.
  • Discussion of mechanisms of nonheritable variability (stochastic fluctuations, physiological responses).

Main Results:

  • Nonheritable variability, arising from random cell events and environmental responses, significantly increases cancer's evolutionary rate.
  • This variability contributes to the development of chemotherapy resistance.

Conclusions:

  • Controlling nonheritable cellular variability is essential for overcoming cancer drug resistance.
  • New drug design approaches are required to effectively manage this evolutionary pressure in cancer treatment.